{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:51:22Z","timestamp":1787842282752,"version":"build-2784847793"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","award":["2016-01576"],"award-info":[{"award-number":["2016-01576"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","award":["2019-06094"],"award-info":[{"award-number":["2019-06094"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","award":["2016-05160"],"award-info":[{"award-number":["2016-05160"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","award":["2019-01209"],"award-info":[{"award-number":["2019-01209"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","award":["2023-02256"],"award-info":[{"award-number":["2023-02256"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","award":["RB13-0156"],"award-info":[{"award-number":["RB13-0156"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Patient Association for Rheumatic Diseases","award":["RR-982095"],"award-info":[{"award-number":["RR-982095"]}]},{"name":"Patient Association for Rheumatic Diseases","award":["R-939149"],"award-info":[{"award-number":["R-939149"]}]},{"name":"Patient Association for Rheumatic Diseases","award":["R-982276"],"award-info":[{"award-number":["R-982276"]}]},{"name":"King Gustav V 80-year foundation","award":["FAI-2022-0876"],"award-info":[{"award-number":["FAI-2022-0876"]}]},{"name":"King Gustav V 80-year foundation","award":["SGI-2022-0936"],"award-info":[{"award-number":["SGI-2022-0936"]}]},{"name":"King Gustav V 80-year foundation","award":["FAI-2020-0663"],"award-info":[{"award-number":["FAI-2020-0663"]}]},{"name":"Swedish government and the county council","award":["ALFGBG-719631"],"award-info":[{"award-number":["ALFGBG-719631"]}]},{"name":"Sweden\u2019s Innovation Agency","award":["2019-03060"],"award-info":[{"award-number":["2019-03060"]}]},{"DOI":"10.13039\/501100012331","name":"Leo Foundation","doi-asserted-by":"publisher","award":["LF-OC-22-001023"],"award-info":[{"award-number":["LF-OC-22-001023"]}],"id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for Assistance to Disabled People in Sk\u00e5ne"},{"DOI":"10.13039\/100016670","name":"Region \u00d6sterg\u00f6tland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016670","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gustafsson Foundation"},{"name":"King Gustaf V and Queen Victoria\u2019s Freemasons Foundation"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>For better management of RA, new biomarkers are needed to predict the development of different disease courses. This study aims to identify autoantibodies against epitopes on proteins in the joints and to predict disease outcome in patients with new onset RA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Sera from new-onset RA patients from the Swedish BARFOT (Better Anti Rheumatic PharmacOTherapy) and TIRA-2 (Swedish acronym for \u2018tidiga insatser vid reumatoid artrit\u2019) cohorts (n\u2009=\u20091986) were screened for autoantibodies to selected peptides (JointIDs) in a bead-based multiplex flow immunoassay. Disease outcomes included Boolean remission 1.0, swollen joint count and radiographic destruction. Multivariate logistic regression and zero-inflated negative binomial models that accounted for clinical factors were used to identify JointIDs with the strongest potential to predict prognosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Boolean remission was predicted with 42% sensitivity and 75% specificity in male patients positive for antibodies to a non-modified collagen type II (COL2) peptide at 12\u2009months. When antibodies to a specific citrullinated cartilage oligomeric protein (COMP) peptide were absent and the patient was in Boolean remission at 6\u2009months, the sensitivity was 13% and the specificity 99%. Positivity for the non-modified COL2 peptide also reduced the frequency of swollen joints by 41% and 33% at 6 and 12\u2009months, respectively. Antibodies to CCP predicted joint destruction with low specificity (58%). Positivity for a COL2 and a glucose-6-phosphate dehydrogenase peptide in citrullinated forms increased specificity (86%) at the expense of sensitivity (39%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Autoantibodies against joint-related proteins at RA diagnosis predict remission with high specificity and, in combination with clinical factors, may guide future treatment decisions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae382","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T01:05:53Z","timestamp":1722387953000},"page":"2227-2232","source":"Crossref","is-referenced-by-count":5,"title":["Autoantibodies to joint-related peptides as predictive markers in early rheumatoid arthritis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4013-7549","authenticated-orcid":false,"given":"Monica","family":"Leu Agelii","sequence":"first","affiliation":[{"name":"Rheumatology and Inflammation Research, Gothenburg University , Gothenburg,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5644-8216","authenticated-orcid":false,"given":"Outi","family":"Sareila","sequence":"additional","affiliation":[{"name":"Rheumatology and Inflammation Research, Gothenburg University , Gothenburg,","place":["Sweden"]},{"name":"Medical Inflammation Research, Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1311-2541","authenticated-orcid":false,"given":"Erik","family":"L\u00f6nnblom","sequence":"additional","affiliation":[{"name":"Medical Inflammation Research, Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Medical Inflammation Research, Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Forslind","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Section of Rheumatology, Lund University , Lund,","place":["Sweden"]},{"name":"Spenshult Research and Development Center , Halmstad,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingi\u00e4ld","family":"Hafstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Medicine Huddinge, Division of Gastroenterology and Rheumatology, and Karolinska University Hospital, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0217-5029","authenticated-orcid":false,"given":"Maria L E","family":"Andersson","sequence":"additional","affiliation":[{"name":"Spenshult Research and Development Center , Halmstad,","place":["Sweden"]},{"name":"Department of Clinical Sciences Lund, Section of Rheumatology, Lund University , Lund,","place":["Sweden"]},{"name":"Department of Environmental and Biosciences, School of Business, Innovation and Sustainability, Halmstad University , Halmstad,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-1477","authenticated-orcid":false,"given":"Alf","family":"Kastbom","sequence":"additional","affiliation":[{"name":"Department of Rheumatology in \u00d6sterg\u00f6tland, Department of Biomedical and Clinical Sciences, Link\u00f6ping University , Link\u00f6ping,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0900-2048","authenticated-orcid":false,"given":"Christopher","family":"Sj\u00f6wall","sequence":"additional","affiliation":[{"name":"Department of Rheumatology in \u00d6sterg\u00f6tland, Department of Biomedical and Clinical Sciences, Link\u00f6ping University , Link\u00f6ping,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4402-148X","authenticated-orcid":false,"given":"Lennart T H","family":"Jacobsson","sequence":"additional","affiliation":[{"name":"Rheumatology and Inflammation Research, Gothenburg University , Gothenburg,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kihlberg","sequence":"additional","affiliation":[{"name":"Department of Chemistry\u2013BMC, Uppsala University , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikard","family":"Holmdahl","sequence":"additional","affiliation":[{"name":"Medical Inflammation Research, Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9301-4844","authenticated-orcid":false,"given":"Inger","family":"Gjertsson","sequence":"additional","affiliation":[{"name":"Rheumatology and Inflammation Research, Gothenburg University , Gothenburg,","place":["Sweden"]},{"name":"Department of Rheumatology, Sahlgrenska University Hospital , Gothenburg,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"2025040212102394100_keae382-B1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/annrheumdis-2021-221653","article-title":"Re-examining remission definitions in rheumatoid arthritis: considering the 28-Joint Disease Activity Score, C-reactive protein level and patient global assessment","volume":"81","author":"Felson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025040212102394100_keae382-B2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/art.30129","article-title":"American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"63","author":"Felson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2025040212102394100_keae382-B3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41467-023-36257-x","article-title":"A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis","volume":"14","author":"He","year":"2023","journal-title":"Nat Commun"},{"key":"2025040212102394100_keae382-B4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/ard-2022-223633","article-title":"Pathogenic antibody response to glucose-6-phosphate isomerase targets a modified epitope uniquely exposed on joint cartilage","volume":"82","author":"Li","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025040212102394100_keae382-B5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2025040212102394100_keae382-B6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/OARRR.S218448","article-title":"A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis\u2014results of clinical relevance","volume":"11","author":"Hafstr\u00f6m","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"2025040212102394100_keae382-B7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/03009742.2020.1771761","article-title":"Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006-2011","volume":"49","author":"Ziegelasch","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"2025040212102394100_keae382-B8","first-page":"261","article-title":"How to read radiographs according to the Sharp\/van der Heijde method","volume":"27","author":"van der Heijde","year":"2000","journal-title":"J Rheumatol"},{"key":"2025040212102394100_keae382-B9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/art.42463","article-title":"Autoantibodies to disease-related proteins in joints as novel biomarkers for the diagnosis of rheumatoid arthritis","volume":"75","author":"L\u00f6nnblom","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2025040212102394100_keae382-B10","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1021\/acschembio.0c00826","article-title":"Correction to synthesis of an array of triple-helical peptides from type ii collagen for multiplex analysis of autoantibodies in rheumatoid arthritis","volume":"15","author":"Viljanen","year":"2020","journal-title":"ACS Chem Biol"},{"key":"2025040212102394100_keae382-B11","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1021\/acschembio.0c00680","article-title":"Synthesis of an array of triple-helical peptides from type II collagen for multiplex analysis of autoantibodies in rheumatoid arthritis","volume":"15","author":"Viljanen","year":"2020","journal-title":"ACS Chem Biol"},{"key":"2025040212102394100_keae382-B12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/00325481.2022.2052626","article-title":"Biomarkers for the diagnosis and treatment of rheumatoid arthritis\u2014a systematic review","volume":"135","author":"Abdelhafiz","year":"2022","journal-title":"Postgrad Med"},{"key":"2025040212102394100_keae382-B13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41591-022-01880-6","article-title":"The promise of precision medicine in rheumatology","volume":"28","author":"Guthridge","year":"2022","journal-title":"Nat Med"},{"key":"2025040212102394100_keae382-B14","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa2312665","article-title":"The role of interferon-gamma in autoimmune polyendocrine syndrome type 1","volume":"390","author":"Oikonomou","year":"2024","journal-title":"N Engl J Med"},{"key":"2025040212102394100_keae382-B15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-020-02191-2","article-title":"Presence of autoantibodies in \"seronegative\" rheumatoid arthritis associates with classical risk factors and high disease activity","volume":"22","author":"Reed","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2025040212102394100_keae382-B16","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","article-title":"Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis","volume":"7","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2025040212102394100_keae382-B17","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001228","article-title":"Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"7","author":"Catrina","year":"2021","journal-title":"RMD Open"},{"key":"2025040212102394100_keae382-B18","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae382\/58906381\/keae382.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/2227\/58906381\/keae382.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/2227\/58906381\/keae382.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T16:31:28Z","timestamp":1743611488000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/2227\/7724121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,7,30]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae382","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,7,30]]}}}